BIOTIME INC 8-K 3-7-2015

Company

Lineage Cell Therapeutics, Inc.

Filed

March 12, 2015

Period of Report

March 7, 2015

Accession Number

0001140361-15-011530

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →